Gulek, Rona D.

HRN: 28-95-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
CEFUROXIME 1.5GM (VIAL)
07/03/2026
07/03/2026
IV
1.5g
PTOR
STAT CS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: